Life ScienceCompany
TetraLogic Pharmaceuticals M&A Summary
TetraLogic Pharmaceuticals has acquired 1 company. It has also divested 1 asset.
It’s largest disclosed sale occurred in 2016, when it sold TetraLogic Pharmaceuticals - Oncology Programs to Medivir AB for $12M. TetraLogic Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include healthcare services (100%).
TetraLogic Pharmaceuticals Business Overview
Where is TetraLogic Pharmaceuticals headquartered?
TetraLogic Pharmaceuticals is headquartered in Malvern, Pennsylvania.
How many employees does TetraLogic Pharmaceuticals have?
TetraLogic Pharmaceuticals has 29 employees.
What sector is TetraLogic Pharmaceuticals in?
TetraLogic Pharmaceuticals is a life science company.
When was TetraLogic Pharmaceuticals founded?
TetraLogic Pharmaceuticals was founded in 2001.
M&A Summary
-
M&A Total Activity2
- M&A Buy Activity1
- M&A Sell Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
Unlimited Searches
